Memorial Ataşehir Hospital
Memorial Ataşehir Hospital
Turkey, Istanbul
Zafer Orkun Toktas
17 years of experience
Clinic is certified :
Mesenchymal stem cell therapy in Turkey typically costs from AUD $7,209 to AUD $14,419. Final pricing depends on the cell source, required dosage, and the specific condition being treated, such as orthopaedic or neurological issues. In Australia, similar treatments average AUD $15,139, meaning patients can save approximately 29% by travelling. Packages generally include diagnostic tests, stem cell processing, VIP transfers, and luxury accommodation in hubs like Istanbul or Izmir.
Bookimed Expert Insight: Choosing a facility with an on-site Good Manufacturing Practice (GMP) laboratory is vital for value. Liv Hospital Ulus, for instance, operates the first private GMP stem cell lab in Turkey. This allows specialists like Professor Erdal Karaöz, who has authored over 150 international articles, to oversee cell quality directly. For Australians, this level of integrated laboratory infrastructure often matches or exceeds private clinic standards at home for a fraction of the cost.
| Turkey | Thailand | ||
| Mesenchymal stem cell therapy | from AUD $7,209 | from AUD $11,535 | from AUD $8,651 |
No hidden fees – just official clinic prices. Pay at the clinic for Mesenchymal stem cell therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Mesenchymal stem cell therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Mesenchymal stem cell therapy journey.
Dr. Sedef Tavukcu Özkan is an anesthesiology and reanimation specialist at VM Medical Park Pendik. She focuses on combining anesthesia expertise with stem cell therapies. Dr. Özkan treats conditions like male infertility and erectile dysfunction using regenerative techniques. She balances her clinical practice with PhD research in health management at Istinye University.
Dr. Erdal Karaöz is a pioneer in regenerative medicine at Liv Hospital Ulus. He established the first private stem cell production center in Turkey under GMP standards. He previously conducted stem cell research at Harvard University in Boston. Dr. Karaöz founded the first institutional stem cell R&D center in Turkey at Kocaeli University.
Dr. Abdulmuttalip Simsek is a urological surgeon at Memorial Bahçelievler Hospital in Istanbul. He specializes in robotic and reconstructive surgery for complex urological conditions. Dr. Simsek holds the rank of Professor and completed reconstructive urology training in the UK. He treats a wide range of cancers including kidney, prostate, and bladder malignancies.
Mesenchymal Stem Cell (MSC) therapy in Turkey is safe when performed in Ministry of Health-approved hospitals. These facilities must have on-site GMP-certified laboratories. Safety is maintained through international accreditations such as JCI and ISO. These bodies require sterile cell processing and rigorous clinical governance standards.
Bookimed Expert Insight: Turkish clinics often host regenerative medicine within large, multi-disciplinary hospitals rather than standalone boutiques. Facilities like Liv Hospital Ulus serve 331,000+ patients annually. This setup provides immediate access to intensive care and specialist anaesthetists if needed during the procedure.
Patient Consensus: Patients in Turkey prioritise hospital-based care over commercial clinics for better safety. They recommend checking if cells are processed under GMP standards. They also suggest confirming ministry approvals before travel.
Turkish clinics treat various autoimmune, orthopaedic, and neurological conditions using mesenchymal stem cell (MSC) therapy. Most treatments address osteoarthritis, multiple sclerosis, autism, and Parkinson's disease. Accredited facilities like Liv Hospital Ulus use GMP-standard laboratories to process cells. These cells come from bone marrow, adipose tissue, or umbilical cord matrix.
Bookimed Expert Insight: In-house GMP (Good Manufacturing Practice) laboratories provide a higher level of cell potency control. One example is LivMedCell led by Professor Erdal Karaöz. Many clinics also combine MSC therapy with neuroplasticity protocols. This helps bridge the gap between treatment and functional recovery.
Patient Consensus: Patients often seek MSC therapy in Turkey for chronic joint pain and neurological conditions. This usually occurs after conventional treatments have failed. Most report a focus on achieving functional improvements and symptom relief rather than a complete cure.
Mesenchymal stem cell therapy in Turkey follows a regulated clinical pathway. It involves online medical evaluation, cell harvesting, and laboratory cultivation in GMP-certified facilities. Specialists in Istanbul and Izmir use adipose tissue, bone marrow, or umbilical cord matrix. These treat neurological, orthopaedic, and systemic conditions.
Bookimed Expert Insight: Many centres focus only on injections. However, top Istanbul facilities like Liv Hospital Ulus operate on-site GMP laboratories. Having a lab within the hospital reduces cell transit time. This maintains higher cell viability than clinics that outsource processing to external facilities.
Patient Consensus: Patients travelling to Turkey value direct access to multidisciplinary teams. Neurologists and lab directors coordinate every step. Streamlined logistics and English-speaking assistance make the complex medical process manageable for international families.
Patients in Turkey generally observe initial results from mesenchymal stem cell (MSC) therapy within 4 to 12 weeks. Some functional gains appear early. However, the biological healing process typically peaks at 6 months as transplanted cells reduce inflammation and support repair.
Bookimed Expert Insight: Turkish clinics often lead in cell processing technology. Liv Hospital Ulus uses an in-house GMP-standard production centre called LivMedCell. This means cells are processed in a sterile environment without being transported. Fresh, high-viability cells often lead to more predictable response times compared to frozen samples.
Patient Consensus: Many report better sleep and mobility within the first month. Most patients suggest tracking daily energy levels and pain scores. This helps identify the gradual improvements that become clear by the 3-month mark in Turkey.
Turkey is a global hub for Mesenchymal Stem Cell (MSC) therapy. It has a dense network of GMP-certified laboratories and internationally accredited hospitals. Centres like Liv Hospital and specialists like Dr Erdal Karaöz help cell production meet strict sterility and safety standards.
Bookimed Expert Insight: Many countries offer stem cell treatments, but Turkey stands out by integrating laboratories directly into hospitals. At Liv Hospital, the GMP lab is on-site. This allows for better traceability and reduces the time cells spend in transit before injection.
Patient Consensus: Patients find Turkey provides faster access to MSC therapy for conditions like autism and neurological disorders. They appreciate the detailed lab reports showing cell counts and the thorough follow-up support during recovery.
Lifestyle habits like smoking and drinking alcohol significantly reduce the success of mesenchymal stem cell (MSC) therapy in Turkey. Nicotine inhibits the regenerative capacity and migration of stem cells. Alcohol can also impair their overall effectiveness. Top clinics, including Liv Hospital Ulus, require managing these habits so transplanted cells thrive.
Bookimed Expert Insight: Many focus only on the procedure, but Turkey's JCI-accredited centres use Good Manufacturing Practice (GMP) labs. These facilities, like those led by Dr Erdal Karaöz, maintain high cell viability. However, even high-quality cells cannot overcome the inflammatory environment caused by active smoking.
Patient Consensus: Many patients find that following a strict pre-treatment plan improves their results. This includes getting better sleep and staying hydrated. They highlight that Turkey's specialists view MSC therapy as part of a broader recovery strategy.
Expected success rates for Mesenchymal Stem Cell (MSC) therapy in Turkey vary from 50% to 95% depending on the condition. Specialised clinics like You Clinic in Izmir report up to 95% success for neurological applications. This includes autism and stroke recovery using GMP-compliant laboratory standards.
Bookimed Expert Insight: Success in Turkey is driven by local laboratory infrastructure rather than just surgical skill. Professor Erdal Karaöz at Liv Hospital Ulus pioneered the first institutional R&D stem cell centre in the country. Patients often find better outcomes at clinics with on-site, GMP-certified labs. These facilities use closed systems to keep cells viable.
Patient Consensus: Many patients report noticeable symptom relief in Turkey. However, they often describe partial improvements rather than complete cures. They suggest verifying the exact cell source and dose directly with the clinic. This helps confirm the protocol matches their specific medical needs.